LRP4 and myasthenia gravis: The underlying mechanism of MG primarily involves the production of autoantibodies that target the acetylcholine receptor (AChR) in 85% of patients [2], However, some patients exhibit autoantibodies against muscle-specific tyrosine kinase (MuSK) and low-density lipoprotein receptor-related protein 4 (LRP4).